US FDA approved drugs from 2015–June 2020: a perspective
In the present work, we report compilation and analysis of 245 drugs, including small and
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …
macromolecules approved by the US FDA from 2015 until June 2020. Nearly 29% of the …
[HTML][HTML] The pharmaceutical industry in 2020. An analysis of FDA drug approvals from the perspective of molecules
BG de La Torre, F Albericio - Molecules, 2021 - mdpi.com
Although the pharmaceutical industry will remember 2020 as the year of COVID-19, it is
important to highlight that this year has been the second-best—together with 1996—in terms …
important to highlight that this year has been the second-best—together with 1996—in terms …
[HTML][HTML] The pharmaceutical industry in 2019. An analysis of FDA drug approvals from the perspective of molecules
BG de la Torre, F Albericio - Molecules, 2020 - mdpi.com
During 2019, the US Food and Drug Administration (FDA) approved 48 new drugs (38 New
Chemical Entities and 10 Biologics). Although this figure is slightly lower than that registered …
Chemical Entities and 10 Biologics). Although this figure is slightly lower than that registered …
[HTML][HTML] The pharmaceutical industry in 2021. An analysis of FDA drug approvals from the perspective of molecules
BG de la Torre, F Albericio - Molecules, 2022 - mdpi.com
Similar to last year, 2021 will be remembered for the COVID-19 pandemic. Although five
vaccines have been approved by the two most important drug regulatory agencies, namely …
vaccines have been approved by the two most important drug regulatory agencies, namely …
An analysis of FDA-approved drugs: natural products and their derivatives
E Patridge, P Gareiss, MS Kinch, D Hoyer - Drug discovery today, 2016 - Elsevier
Highlights•Natural products contribute more than one-third of all FDA-approved NMEs.•The
absolute number of natural product approvals peaked in the 1990s and has since …
absolute number of natural product approvals peaked in the 1990s and has since …
[HTML][HTML] The pharmaceutical industry in 2022: an analysis of FDA drug approvals from the perspective of molecules
BG de la Torre, F Albericio - Molecules, 2023 - mdpi.com
While 2021 ended with the world engulfed in the COVID-19 Omicron wave, 2022 has ended
in almost all countries, except China, with COVID-19 being likened to the flu. In this context …
in almost all countries, except China, with COVID-19 being likened to the flu. In this context …
A decade of FDA-approved drugs (2010–2019): trends and future directions
A total of 378 novel drugs and 27 biosimilars approved by the US Food and Drug
Administration (FDA) between 2010 and 2019 were evaluated according to approval …
Administration (FDA) between 2010 and 2019 were evaluated according to approval …
Anticancer drugs approved by the US food and drug administration from 2009 to 2020 according to their mechanism of action
Importance Both novel and next-in-class cancer drugs have a role in oncology, but the
relative development of each is understudied. Objective To characterize the mechanisms of …
relative development of each is understudied. Objective To characterize the mechanisms of …
New drug approvals for 2020: Synthesis and clinical applications
Abstract 53 New drugs including 38 chemical entities and 15 biologics were approved by
the US Food and Drug Administration during 2020. Among the marketed drugs, 34 new …
the US Food and Drug Administration during 2020. Among the marketed drugs, 34 new …
An overview of FDA-approved new molecular entities: 1827–2013
MS Kinch, A Haynesworth, SL Kinch, D Hoyer - Drug discovery today, 2014 - Elsevier
Highlights•1453 new molecular entities (NMEs) approved as therapeutics in the USA.•As a
consequence of consolidation, ten companies control more than two-thirds of all …
consequence of consolidation, ten companies control more than two-thirds of all …